Rosiglitazone Heart Attack
Links shared publicly online about this topic
Avandia (rosiglitazone) Use To Be Severely Restricted
medicalnewstoday.com — “The use of diabetes medication, Avandia (rosiglitazone) is to be significantly restricted to patients with diabetes Type 2 who are unable to control their diabetes on other drugs, the Food and Dru” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 10:06 pm By:
Avandia (rosiglitazone) Use To Be Severely Restricted The use of diabetes medication, Avandia (rosiglitazone) is to be .. http://dld.bz/wMFQ
Diabetes Drug Rosiglitazone Not Associated With Increased Risk Of Death, Stroke Or Heart Attacks In BARI 2D Study
medicalnewstoday.com — “Rosiglitazone, a commonly used diabetes drug, poses no significant increased risk of death, stroke or heart attack, though it does increase the risk of fractures, according to a new analysis of th” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 12:36 pm By:
MNT Cardiovascular Health News
Diabetes Drug Rosiglitazone Not Associated With Increased Risk Of Death, Stroke Or Heart Attacks In BARI 2D Study http://mnt.to/3Fvq
Rosiglitazone therapy associated with increased risk for heart attack: Study
news-medical.net — “Eleven years after the introduction of the diabetes drug rosiglitazone, data from available clinical trials demonstrate an increased risk for heart attack associated with its use and suggest an unfavorable benefit-to-risk ratio, according to a report posted online today that will appear in the July 26 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals.” View full resource at news-medical.net
Most Recently Shared on June 29, 2010 at 12:04 pm By:
Rosiglitazone therapy associated with increased risk for heart attack: Study: Eleven years after the introduction ... http://bit.ly/9zOoQx
Symposier - Insidermedicine In Depth - Avandia (Rosiglitazone) Heart Risk
symposier.com — “Uploaded and shared in Youtube by: insidermedicine " A new analysis of several previous studies confirms that taking rosiglitazone, more commonly known as Avandia, actually increases the chances of having a heart attack but not the risk of dying of a cardiovascular cause. The study is published online ahead of print in the Archives of Internal Medicine. Here is some information about rosiglitazone: It is a drug used to treat type 2 diabetes, which works by helping to increase the body's sen” View full resource at symposier.com
Most Recently Shared on July 7, 2010 at 1:50 am By:
Symposier Endocrino Health Site
Insidermedicine In Depth - Avandia (Rosiglitazone) Heart Risk. http://bit.ly/cJT7kJ
No link between diabetes drug rosiglitazone and increased rate of heart attack, study finds: The diabetes drug ros... http://bit.ly/cYGPAj
sciencedaily.com — “No link between diabetes drug rosiglitazone and increased rate of heart attack, study finds: The diabetes drug ros... http://bit.ly/cYGPAj” View full resource at sciencedaily.com
Most Recently Shared on June 29, 2010 at 2:06 pm By:
No link between diabetes drug rosiglitazone and increased rate of heart attack, study finds: The diabetes drug ros... http://bit.ly/cYGPAj
No Association Between Diabetes Drug Rosiglitazone (Avandia) And Increased Rate Of Heart Attack
medicalnewstoday.com — “The diabetes drug Avandia (rosiglitazone) has been under intense scrutiny since a study published in the New England Journal of Medicine (NEJM) in 2007 looked at over 40 clinical trials and” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2010 at 6:10 pm By:
MedicalNewsToday: No Association Between Diabetes Drug Rosiglitazone (Avandia) And: http://bit.ly/ddfYJ7 Full http://bit.ly/aScwLE
Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events
fda.gov — “UPDATED 02/04/2011. Information on the cardiovascular risks (including heart attack) of rosiglitazone has been added to the physician labeling and patient Medication Guide.” View full resource at fda.gov
Most Recently Shared on February 9, 2011 at 2:11 am By:
madan kwatra Doctor and PhD
Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events http://t.co/W4Kc9fD via @AddThis
Avandia (rosiglitazone): REMS - Risk of Cardiovascular Events
fda.gov — “UPDATED 02/04/2011. Information on the cardiovascular risks (including heart attack) of rosiglitazone has been added to the physician labeling and patient Medication Guide.” View full resource at fda.gov
Most Recently Shared on February 4, 2011 at 6:29 pm By:
Lisa Morris Bonsall Nurse and Advanced Practice Nurse
Risk of cardiovascular events with Avandia http://bit.ly/g6Emmg
Avandia (rosiglitazone) Use To Be Severely Restricted - QualityPoint Technologies
qualitypointtech.net — “The use of diabetes medication, Avandia (rosiglitazone) is to be significantly restricted to patients with diabetes Type 2 who are unable to control their diabetes on other drugs, the Food and Drug Administration (FDA) has announced. FDA officials say this is after evaluating data which links Avandia to a higher risk of stroke and cardiovascular events, such as heart attack. FDA Commissioner Margaret A. Hamburg, M.D., said: The FDA is taking this action today to protect patients, after a careful” View full resource at qualitypointtech.net
Most Recently Shared on September 24, 2010 at 8:24 am By:
Avandia (rosiglitazone) Use To Be Severely Restricted: The use of diabetes medication, Avandia (rosiglitazone) is ... http://bit.ly/cKjUby
Rosiglitazone safety questioned, again
theheart.org — “The drug was associated with more deaths and more heart failure than pioglitazone in an analysis of outpatients from across Ontario; no difference was seen in the risk of MI.” View full resource at theheart.org
Most Recently Shared on August 19, 2009 at 8:16 pm By:
heartwire: Rosiglitazone safety questioned, again, this time in population-based study http://bit.ly/3q9XKE
Study: Diabetes drug Avandia (rosiglitazone) just as safe as Actos (pioglitazone) http://bit.ly/b5ImCR - Hmmm... #health
reuters.com — “Study: Diabetes drug Avandia (rosiglitazone) just as safe as Actos (pioglitazone) http://bit.ly/b5ImCR - Hmmm... #health” View full resource at reuters.com
Most Recently Shared on August 24, 2010 at 11:45 pm By:
Hisham Rana, MD Doctor and Physician
Study: Diabetes drug Avandia (rosiglitazone) just as safe as Actos (pioglitazone) http://bit.ly/b5ImCR - Hmmm... #health
Trigger Found For Autoimmune Heart Attacks
medicalnewstoday.com — “People with type 1 diabetes, whose insulin-producing cells have been destroyed by the body's own immune system, are particularly vulnerable to a form of inflammatory heart disease (myocarditis) ca” View full resource at medicalnewstoday.com
Most Recently Shared on March 24, 2011 at 8:05 am By:
MNT Cardiovascular Health News
Trigger Found For Autoimmune Heart Attacks http://mnt.to/3SFk #cardiovascular
Diabetes Type 2 Drug Avandia (Rosiglitazone) Linked To Higher Stroke, Heart Failure And Death Risk Compared To Actos (Pioglitazone)
medicalnewstoday.com — “Patients aged at least 65 years who have diabetes type 2 and take Avandia (Rosiglitazone) have a higher risk of developing stroke, heart failure, and even dying compared to similar patients who ta” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2010 at 4:40 pm By:
Diabetes Type 2 Drug Avandia (Rosiglitazone) Linked To Higher Stroke, Heart Failure And Death Risk Compared To Act... http://mnt.to/f/3Fwy
Diabetes Drugs Avandia (rosiglitazone) And Actos (pioglitazone) Have Same Heart Disease And Death Risks
medicalnewstoday.com — “A new analysis of diabetes medications Avandia (rosiglitazone) and Actos (pioglitazone) revealed that the risk of heart attack and/or heart failure, or death were the same, approximately 4%. The” View full resource at medicalnewstoday.com
Most Recently Shared on August 25, 2010 at 3:00 pm By:
MedicalNewsToday: Diabetes Drugs Avandia (rosiglitazone) And Actos (pioglitazone) Have Same: http://bit.ly/9VJslp Full http://bit.ly/cWSIfH
British said rosiglitazone should be withdrawn; Europeans discuss | theheart.org
theheart.org — “It has emerged this week that UK experts recommended the withdrawal of the diabetes drug rosiglitazone from the British market in July, although this recommendation was not made public at the time. However, because the drug was approved centrally by the European Medicines Agency, only it can revoke the license, says the UK regulatory body; the EMA is discussing rosiglitazone today, although no final decision is expected on the product until the end of this month.” View full resource at theheart.org
Most Recently Shared on September 8, 2010 at 7:41 pm By:
UK experts advised rosiglitazone withdrawal in July: It has emerged this week that UK experts recommended the with... http://bit.ly/at4B7L
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
MNT Cardiovascular
The latest cardiovascular news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Medical News from Around the World
Advertisement
